Two NYU medical school professors say it shows how wounded FDA is politically when drug companies feel a need to reassure the public that they wont di...
The September Kaiser Family Foundation health tracking poll shows that many people fear that political pressure will force FDA to rush approval of a C...
Janssen Pharmaceutical Companies files a supplemental BLA for Darzalex FasPro (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of dara...
FDA warns 17 Web site operators that they are illegally selling unapproved and misbranded opioids.
The eight top FDA career executives write in a USA Today opinion piece that they are committed to following the science within the political environme...
FDA trepidation with gene therapies continues as it holds up a Sarepta Therapeutics clinical trial by asking for an additional potency assay to releas...
FDA approves a GlaxoSmithKline a supplemental NDA for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for treating asthma in patients ag...
FDA commissioner Stephen Hahn and associate commissioner Anand Shah say its time for investments and incentives to be added to FDAs efforts to bring m...